Corbus Pharmaceuticals Holdings, Inc.
Status: Publicly traded
Direct answer
Corbus Pharmaceuticals Holdings, Inc. is publicly traded on NASDAQ under the ticker CRBP.
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells,...
Can you invest in Corbus Pharmaceuticals Holdings, Inc.?
Yes. Corbus Pharmaceuticals Holdings, Inc. is publicly traded on NASDAQ under the ticker CRBP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Corbus Pharmaceuticals Holdings, Inc.
Detailed equity research is provided by MarketSnap.